Sign in

CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

MapLight Therapeutics, Inc.

Sign in to watch
Ticker
MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832163243
Phone
650-839-4360
Business address
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Alvarado Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,256,232
in 7 filings, $193K under 10b5-1 plans

Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
  2. Hanson Kristopher −$266K General Counsel sold 17% of stake
  3. Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
  4. Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
  5. Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2026-01-27 Lillie James Woodruff Chief Scientific Officer Shares withheld for taxes −45,055 $17.98 $810K 291,132
2026-01-27 GILLIS JONATHAN CAAO and PAO Shares withheld for taxes −22,050 $17.98 $396K 248,503
2026-01-27 Kroeger Christopher A. Chief Executive Officer Shares withheld for taxes −204,146 $17.98 $3.7M 1,626,606
2025-10-28 Novo Holdings A/S 10% owner Conversion +2,733,681 2,733,681
2025-10-28 Novo Holdings A/S 10% owner Purchase +952,941 $17.00 $16.2M 3,686,622
2025-10-28 Novo Holdings A/S 10% owner Conversion · Series C Preferred Stock −26,191,207 0
2025-10-28 Novo Holdings A/S 10% owner Conversion · Series D Preferred Stock −19,734,671 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion +14,256,288 14,256,288
2025-10-28 Catalyst4, Inc. 10% owner Purchase +5,441,176 $17.00 $92.5M 19,697,464
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series A Preferred Stock −148,809 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series A-1 Preferred Stock −444,846 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series B Preferred Stock −1,263,768 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series B-1 Preferred Stock −275,148 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series C Preferred Stock −5,444,807 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series D Preferred Stock −6,678,910 0
2025-10-28 Malenka Robert C. Director Conversion +3,895 31,672
2025-10-28 Malenka Robert C. Director Conversion · Series C Preferred Stock −65,477 0
2025-10-28 Kroeger Christopher A. Chief Executive Officer Conversion +3,895 229,588
2025-10-28 Kroeger Christopher A. Chief Executive Officer Conversion · Series C Preferred Stock −65,477 0
2025-10-27 Setia Vishwas Chief Financial Officer Grant or award +43,367 43,367

Page 11 of 12 · 239 trades